Challands, France

Jacquy Lebon

This inventor holds 23 USPTO granted patents and 4 published patent applications, plus 4 CIPO patents and 12 EPO patents, primarily in Pharmaceutical Packaging. Top assignees: Clariant Production (France) S.a.s., Clariant Healthcare Packaging (France) S.a.s., Airnov, Inc.. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jacquy Lebon. Retrieved from https://idiyas.com/inventor/jacquy-lebon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 23 

% Patents Active = 95.7


 

Average Co-Inventor Count = 1.8

ph-index = 7

Forward Citations = 162(Granted Patents)


Location History:

  • Challands, FR (2011 - 2022)
  • Challans, FR (2018 - 2023)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Active Substance
Tamper-Evident Closure
Child-Resistant Closure
Medical Container
Pharmaceutical Products
Flow-Limiting Device
Dispensing Opening
Canister
Stopper
Screw Cap
Container Assembly
23 patents (USPTO):Explore Patents

Title: Innovations by Jacquy Lebon: Pioneering Patents in Active Substance Containers

Introduction

Jacquy Lebon, an accomplished inventor based in Challands, France, has made significant contributions to the field of packaging and containment solutions. With a remarkable portfolio of 22 patents, Lebon is recognized for his innovative approaches to creating effective and secure receptacles for active substances.

Latest Patents

Two of Jacquy Lebon's latest patents showcase his expertise in the design of advanced packaging solutions. The first patent introduces a "Receptacle for holding an active substance and corresponding closure and container." This receptacle forms a chamber partially filled with an active substance, which is comprised of a body and a cap that securely closes the body. The cap features a top wall with a primary side facing the chamber's interior, while a skirt encircles the sidewall, forming a compact joint that ensures the chamber is effectively sealed. Importantly, at least one ventilation path connects the chamber to the external atmosphere, allowing for controlled ventilation.

The second patent, a "Tamper-evident closure, container with such closure and its use," details an innovative closure mechanism for containers with outer screw thread openings. This sophisticated design includes both an outer cap and an inner cap that is coaxially nested, featuring cooperating engagement mechanisms that activate a tamper-evident member upon the first use. The incorporation of a frangible component ensures that any tampering results in visible damage, thereby enhancing the security of the container's contents.

Career Highlights

Throughout his career, Jacquy Lebon has showcased his inventive prowess while working with notable companies such as Clariant Production (France) S.A.S. and Clariant Healthcare Packaging (France) S.A.S. His experiences at these organizations have provided him with a wealth of knowledge, allowing him to refine his innovative designs further.

Collaborations

Jacquy has had the privilege of collaborating with talented individuals in his field, including coworkers Caroline Pot and Valere Logel. Their collective expertise undoubtedly contributes to the innovative solutions that emerge from their partnerships.

Conclusion

In summary, Jacquy Lebon stands out as a leading figure in the realm of inventions focused on packaging solutions for active substances. His commitment to innovation is evident in his numerous patents, which aim to enhance the effectiveness and safety of containment systems. As he continues to develop groundbreaking inventions, the impact of his work will undoubtedly resonate within the industry for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…